Suppr超能文献

头孢沙定(CGP 9000)在人体中的药代动力学。

Pharmacokinetics of cefroxadin (CGP 9000) in man.

作者信息

Gerardin A, Lecaillon J B, Schoeller J P, Humbert G, Guibert J

出版信息

J Pharmacokinet Biopharm. 1982 Feb;10(1):15-26. doi: 10.1007/BF01059181.

Abstract

The pharmacokinetics of cefroxadin have been studied after the administration of single oral and intravenous doses to healthy volunteers. Cefroxadin was assayed by HPLC. The kinetics in plasma following i.v. administration were described by using a three-compartment model. An additional disposition phase was observed following oral administration that could not be detected after the low i.v. dose. The terminal half-life was 1.03 h. The apparent volume of distribution at the steady state was consistent with a diffusion of the antibiotic in all extracellular fluids. The AUC after oral administration was linearly related to the dose. The urinary excretion amounted to 95% of the dose with virtually complete absorption of orally administered drug.

摘要

已对健康志愿者单次口服和静脉注射头孢沙定后的药代动力学进行了研究。采用高效液相色谱法测定头孢沙定。静脉给药后血浆中的动力学用三室模型描述。口服给药后观察到一个额外的处置相,低静脉剂量给药后未检测到该相。终末半衰期为1.03小时。稳态时的表观分布容积与抗生素在所有细胞外液中的扩散一致。口服给药后的药时曲线下面积与剂量呈线性关系。尿排泄量占剂量的95%,口服给药的药物几乎完全吸收。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验